Variants studied for Tramadol response

Minimum submission review status:		Collection method:
Minimum conflict level: Report conflict between different conditions
Gene type: Distinguish antisense genes from sense genes
Show significances as they were submitted (without aggregation into standard terms)
		ClinVar version:

If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.

pathogenic	likely pathogenic	uncertain significance	likely benign	benign	drug response	total
0	0	0	0	0	1610	1610

Gene and significance breakdown #

Total genes and gene combinations: 17

Download table as spreadsheet

Gene or gene combination	drug response	total
ABCB1	567	567
OPRM1	453	453
CYP2D6	186	186
UGT2B7	120	120
ARVCF, COMT	87	87
COMT	71	71
CYP2D6, LOC110740340	49	49
ABCB1, RUNDC3B	23	23
ABCB1, LOC126860097	20	20
IPCEF1, OPRM1	13	13
LOC114803476, UGT2B7	9	9
COMT, TXNRD2	4	4
COMT, LOC112694766	2	2
COMT, LOC130066960, TXNRD2	2	2
COMT, LOC130066961	2	2
COMT, LOC130066962	1	1
COMT, MIR4761	1	1

Submitter and significance breakdown #

Total submitters: 1

Download table as spreadsheet

Submitter	drug response	total
Bruce Budowle Laboratory, University of North Texas Health Science Center	1610	1610

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.